Alumis skin disease drug meets main goal of two late-stage trials
By Thomson ReutersJan 6, 2026 | 6:10 AM
Jan 6 (Reuters) – Alumis said on Tuesday its experimental pill met the main goal in two late-stage studies in patients with a type of skin disease.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Shailesh Kuber)
For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at 715-842-1672.
